STAT

Epic confronts unprecedented challenges as it prepares to address customers and unveil road map

The Surprising Reason This Biotech Plummeted 69%

EyePoint Pharmaceuticals shares cratered following a late-stage trial setback for its flagship eye disease drug.

Epic’s alleged anticompetitive practices under scrutiny from federal, state investigators

FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

US wait times for cancer surgeries are getting longer and longer

Major PBMs to boost prescription drug price transparency through TrumpRx

Eli Lilly is suing six companies over illegal sales of its unapproved weight loss drug

Stopping statins in people over 75 at low risk for heart disease didn’t increase deaths

Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs

Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety

FDA to require notice of additives in food supply for the first time

In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment

WHO says Congo’s Ebola outbreak started months before it was declared

Why Vertex Pharma Popped, As A Key Rival Plummeted 90%

FDA approves Replimune melanoma drug previously rejected twice

A new flu vaccine geared to older people is coming soon

‘Greg, you’ve got to bring back this platform’: How LifeMine won over Gates and Bezos for $188M series E

Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments

First poo transplant to treat food allergy in people has ‘exciting’ results

The ethical perils of gene therapy

Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak

Eli Lilly to allow more patients to apply for special access to unapproved obesity drug

Micron, Bristol Myers, Palantir, Circle Internet, SpaceX, and More Stocks That Explain Today’s Market

Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline

5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

FDA Panel Votes In Favor of Replimune’s Melanoma Treatment

9 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial

5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Weight-loss joke turns serious as 'cyclospora skinny' trend fuels health warnings

9 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

How AI could redefine healthcare by the end of the decade

5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Hot Peptide Summer Is Almost Here

5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Argenx to Buy Forte Biosciences for $2.2 Billion

8 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug

Capricor Therapeutics shares have plunged after FDA staff raised concerns regarding the efficacy and data of its Duchenne heart disease therapy.

We’re beating heart disease

The FDA has approved the first oral medication designed to replace injectable treatments for high cholesterol.

Death of girl in Chinese gene-editing trial kept secret: Report

5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

Trump's former top food official: Cyclospora outbreak ‘approaching catastrophic’ level

A former FDA commissioner warns that the federal response to a multi-state Cyclospora outbreak is approaching a 'catastrophic' level.

First person gets new experimental vaccine for Ebola

The world's first vaccine targeting the Bundibugyo ebolavirus has entered human clinical trials following the first volunteer vaccination.

U.S. health officials investigate new outbreak of parasite cyclospora

7 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Eli Lilly Preparing Retatrutide Applications After Positive Weight-Loss Data

5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

A Peptide Showdown: F.D.A. Scientists May Clash With R.F.K.’s Agenda

4 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

FDA reviews peptide injections favored by RFK Jr. and wellness influencers

The FDA is convening an advisory panel to evaluate seven peptides, prompting a debate over federal oversight and the future of compounding.

Staying in a job for the health insurance? About 1 in 4 Americans do, a survey says

A new survey indicates that approximately one in four American workers remain in jobs they dislike primarily to maintain their health insurance.

4 more executives leaving Epic: Report

Reports of four additional executive departures at Epic Systems have sparked questions about a potential leadership exodus within the health tech giant.

Unpacking Anthropic's 100-day sprint into biopharma: Nobel hires, M&A and major ambition

5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Counterpoint

5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

Bristol Myers says it will build pharma's 'most powerful' AI supercomputer with Nvidia

Bristol Myers Squibb is partnering with Nvidia to build what it describes as the most powerful AI supercomputer in the life sciences industry.

Testosterone: Maga’s latest obsession

5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

UnitedHealth Stock: The 1 Number in the Earnings Beat That Has Shares Jumping

4 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Kalshi Will Offer Sports-Style Betting on Drug Trial Results

4 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

The F.D.A. Approves a New Pill to Slash Cholesterol Levels

The FDA has approved Lipfendra, the first-of-its-kind oral PCSK9 inhibitor designed to significantly reduce cholesterol levels.

Biologists pinpoint how common virus triggers multiple sclerosis

7 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

Health emergency preparedness nominee walks back comments skeptical of vaccine safety

Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits

8 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Alzheimer's blood test may predict who's likely to develop symptoms in 5 to 10 years

13 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease

New clinical studies indicate that a blood test may identify individuals at high risk for developing Alzheimer’s disease years before symptoms appear.

An experimental Alzheimer's drug shows some promise as researchers hunt new approaches

Researchers and investors are evaluating new clinical data from Biogen as the firm explores tau-targeting treatments for Alzheimer’s disease.

All eyes on data on Biogen’s tau therapy

4 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

A breakthrough in pancreatic cancer has experts excited

7 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

Major international trial finds healthy behaviors help brain health in older adults

International trial finds healthy behaviors improve brain health in older adults

Which ‘AI scientist’ suits your lab? A guide for the perplexed

5 news sources are covering this Technology story right now — Newsylist is tracking how fast it spreads.

Last American polio survivor in an iron lung dies at 78

25 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

AstraZeneca, Ionis report major trial failure with heart disease drug

5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.